HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.
HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.